PLOD3 and squamous cell carcinoma: Furthermore, PLOD3 was upregulated in 37 squamous cell carcinoma patients, 15 adenocarcinoma patients, and 7 others compared to that in the corresponding tumors from the same patients (Supplementary figure 1a).